Â鶹¾«Ñ¡

• Fellow of the Higher Education Academy, 2013
• DPhil in immunology, University of Oxford, 1997
• MA in Natural Sciences, University of Cambridge, 1994

Victoria Heath is a Senior Lecturer in Molecular Biology in the Department of Cardiovascular Sciences at the University Â鶹¾«Ñ¡. She did her undergraduate studies in Natural Sciences at the University of Cambridge, followed by a DPhil in the MRC Cellular Immunology Unit in the Sir William Dunn School of Pathology at Oxford University. She then did post-doctoral work at both DNAX Research Institute in Palo Alto, California, working on cell signalling in T helper cell differentiation and at Stanford University on calcium signalling in budding yeast.

She returned to the UK and worked as a Beit Memorial Fellow in the School of Biosciences at the University Â鶹¾«Ñ¡ studying phosphoinositide signalling joining the Molecular Angiogenesis group as a Lecturer in 2006. Since then, her work is focused on identifying the roles of various endothelial expressed signalling molecules in endothelial cell biology and in the development of new blood vessels.  She has received funding from the and Medical Research Council and trained a number of PhD students in this field.

She is interested in developing education within the University Â鶹¾«Ñ¡ and has set up and developed number of modules on a range of programmes including the Biomedical Sciences BSc,  the intercalated Clinical Science BMedSc degree and as part of the Birmingham Foundation Academy.

• BSc Biomedical Sciences
• BDS
• MBChB
• Biomedical Research: Cardiovascular Sciences MRes

Victoria is keen to supervise students in the field of molecular regulation of blood vessel formation both in the context of normal development and cancer biology.  Please email v.heath@bham.ac.uk to make enquiries.

Current PhD students: Werther Vecchiato, Mona Salem

Previous PhD students: Sukhbir Kaur, Katarzyna Leszczynska, Eleanor Wilson and Victoria Simms. 

Research Themes

Cardiovascular Sciences and Cancer biology

Research Activity

Victoria is interested in determining the role of novel endothelial expressed genes in endothelial cell biology and angiogenesis. Angiogenesis, the development of new blood vessels, plays a critical role in tumour growth and metastasis as well as in diseases such as atherosclerosis. A current interest of our group is to determine the biological role of RhoJ, a small Rho GTPase, in endothelial cells.   This gene, which is closely related to Cdc42, is highly and specifically expressed in endothelial cells and is involved in regulating endothelial cell movement and in vitro tube formation. We have identified the binding partners of RhoJ and are continuing to explore the molecular regulation of this Rho GTPase and its role in various models of angiogenesis in vivo. 

In addition, we have identified some novel cell surface proteins involved in angiogenesis and are determining their molecular function and role in vessel formation.